Rohit Loomba MD MHSc

Hepatology & Liver Transplantation

Chief, Division of Gastroenterology and Hepatology, Professor of Medicine with tenure, UC San Diego

Summary

Dr. Rohit Loomba is a gastroenterologist based in La Jolla, CA, specializing in hepatology and liver transplantation. He undertook his gastroenterology fellowship at the University of California San Diego Medical Center and transplant hepatology fellowship at the National Institutes of Health. He also holds an MHS in Clinical Research from Duke University School of Medicine. Currently, he is a tenured professor at the University of California San Diego School of Medicine since 2016. Dr. Loomba has expertise in general gastroenterology, hepatology, viral hepatitides, non-alcoholic fatty liver disease, and hepatic cirrhosis. His research contributions include numerous publications on liver diseases, and he has been actively involved in various clinical trials related to liver conditions. Dr. Loomba's honors include his election to the Association of American Physicians in 2023 and recognition as a highly cited researcher by Clarivate.

Rohit Loomba, MD, MHSc

Dr. Rohit Loomba is Chief, Division of Gastroenterology and Hepatology, and Director, MASLD Research Center, University of California at San Diego

University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2007 - 2009
Duke University School of MedicineMHS, Clinical Research, 2005 - 2007
Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2004 - 2007
St Luke's HospitalResidency, Internal Medicine, 2000 - 2003
ArMed Forces Medical College PuneClass of 1999

Inducted as an elected member Association of American Physicians (AAP), 2023
Clarivate™ Highly Cited Researcher Across All Fields in Science Globally Web of Science, 2020
Clarivate™ Highly Cited Researcher - 1 in a 1000 based upon global impact Web of Science, 2019

PubMed

Journal Articles

The Lancet Child & Adolescent Health
Arun Sanyal, Stephen A Harrison, Edgar D Charles, Stephanie Noviello, Manal F Abdelmalek, Eric J Lawitz, Rohit Loomba, The Lancet
Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis
Rohit Loomba, Ariel E Feldstein, The Journal of Immunology
Author Correction: Inflammation-Induced IgA+ Cells Dismantle Anti-Liver Cancer Immunity
Rohit Loomba, MD, Nature

Abstracts/Posters

Treatment with selonsertib, an inhibitor of apoptosis signal regulating kinase 1, hepatic phospho-p38 expression and markers of hepatocellular apoptosis and necrosis i...
Diehl A.M., French D, Xu R, Loomba R, Lawitz E, Freilich B, Shiffman M.L., Chalasani N, Hameed B, Caldwell S, Rinella M, Peach M, Huntzicker E, Turner S, Sullivan T, C..., EASL, 1/1/2017
Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis treated with selonsertib is associated with improvement of patient-reported outcomes (PROS)
Younossi Z.M., Stepanova M, Goodman Z, Lawitz E, Charlton M, Loomba R, Hunt S., EASL, 1/1/2017
Methylation signatures in blood show accelerated epigenetic aging in patients with non-alcoholic steatohepatitis compared to healthy controls.
Loomba R, Gindin Y, Jiang Z, Lawitz E, Djedjos C.S., Caldwell S, Xu R, Gong D, Myers R.P., Subramanian G.M., Goodman Z, Charlton M, Afdhal N.H., A.M. Diehl A.M., EASL, 1/1/2017

Lectures

Novel Imaging and Management of NASH
1/1/2017
Imaging assessment of NAFLD
Northwestern University, Chicago, IL - 1/1/2016
Novel phenotyping and imaging advances in NAFLD
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) - 1/1/2016